Role of non-Smad signaling pathways in transforming growth factor beta (TGFβ)-induced expression of chondroitin sulfate proteoglycans (CSPGs) by reactive astrocytes
dc.contributor.author | Jahan, Naima | |
dc.contributor.examiningcommittee | Hombach-klonisch, Sabine (Human Anatomy and Cell Science) Karimi, Soheila (Physiology) | en_US |
dc.contributor.supervisor | Hannila, Sari (Human Anatomy and Cell Science) | en_US |
dc.date.accessioned | 2013-12-11T20:19:29Z | |
dc.date.available | 2013-12-11T20:19:29Z | |
dc.date.issued | 2013-12-11 | |
dc.degree.discipline | Human Anatomy and Cell Science | en_US |
dc.degree.level | Master of Science (M.Sc.) | en_US |
dc.description.abstract | Chondroitin sulphate proteoglycans (CSPGs) from the glial scar inhibit axonal regeneration following spinal cord injury. CSPG expression can be induced by transforming growth factor β (TGFβ), which suggests that inhibition of TGFβ may reduce CSPG levels. Astrocytes were treated with cyclic AMP (cAMP), which reduced TGFβ signaling protein Smad2 in astrocytes. However, cAMP-treated astrocytes showed strong neurocan expression following TGFβ treatment, which suggests that TGFβ may mediate CSPG expression through non-Smad pathways. Smad2 or Smad4 were knocked down in astrocytes using siRNA and TGFβ-induced neurocan, brevican and aggrecan expression were still observed, indicating that Smad signaling is not required for CSPG expression. Administration of a PI3K/Akt inhibitor produced significant reductions in neurocan, brevican and aggrecan expression in astrocytes, which suggests that PI3K/Akt pathway mediates CSPG expression. Erk1/2 inhibitor treatment did not reduce CSPG expression significantly. Targeting non-Smad signaling pathways may therefore be effective strategies to reduce CSPG expression following injury. | en_US |
dc.description.note | February 2014 | en_US |
dc.identifier.uri | http://hdl.handle.net/1993/22301 | |
dc.language.iso | eng | en_US |
dc.rights | open access | en_US |
dc.subject | transforming growth factor beta | en_US |
dc.subject | TGFβ | en_US |
dc.subject | chondroitin sulfate proteoglycans | en_US |
dc.subject | CSPGs | en_US |
dc.subject | astrogliosis | en_US |
dc.title | Role of non-Smad signaling pathways in transforming growth factor beta (TGFβ)-induced expression of chondroitin sulfate proteoglycans (CSPGs) by reactive astrocytes | en_US |
dc.type | master thesis | en_US |